Monday, March 25, 1:30 p.m. – 3:00 p.m.
Opening Keynote Speaker
Greg Simon
Greg Simon is the President of the Biden Cancer Initiative. He previously served as the Executive Director of the White House Cancer Moonshot Task Force, a position created by President Barack Obama and for which he was chosen by Vice President Joe Biden in March 2016. Over nine months, Greg and his team helped launch over seventy innovative collaborations. Greg returned to the White House after serving as Vice President Al Gore’s Chief Domestic Policy Advisor between 1993 and 1997. He was the CEO of Poliwogg, a financial services company creating unique capital market opportunities in healthcare and life sciences. Previously, Greg was Senior Vice President for Worldwide Policy and Patient Engagement at Pfizer, co-founded with Michael Milken, FasterCures/ The Center for Accelerating Medical solutions, and with Leon and Debra Black co-founded the Melanoma Research Alliance. Greg is a cancer survivor, having been recently successfully treated for chronic lymphocytic leukemia.
Thursday, March 28, 3:30 p.m. – 5:00 p.m.
Closing Keynote Speaker
Kathy L. Hudson, PhD
Kathy L. Hudson, PhD, is the first CEO of the People-Centered Research Foundation; a nonprofit organization committed to accelerating patient-driven research by leading a large national clinical research network. The network seeks to transform the design, conduct, dissemination, and implementation of research to improve health and health care.
Dr. Hudson is the former Deputy Director for Science, Outreach, and Policy at the National Institutes of Health (NIH). Dr. Hudson led the science policy, legislation, communications, and outreach efforts of the NIH and served as senior advisor to the NIH director. She directed the agency’s efforts to advance biomedical science through policy development and innovative projects and partnerships. Dr. Hudson created major new strategic and scientific initiatives including the National Center for Advancing Translational Sciences, the BRAIN Initiative, the NIH Precision Medicine Initiative, and the Cancer Moonshot. She led the development of major policies that enable science to advance more rapidly including enhancing clinical trials, data sharing, and participation of patients as partners in research. She was the key NIH architect responsible for modernizing the regulations governing research with human subjects.
Dr. Hudson’s professional experience includes serving as the Acting Deputy Director of the National Center for Advancing Translational Sciences, NIH; the NIH Chief of Staff; the Assistant Director of the National Human Genome Research Institute, NIH; and the founder and Director of the Genetics and Public Policy Center at John Hopkins University. Also, at Hopkins, Dr. Hudson was an Associate Professor in the Berman Institute of Bioethics, Institute of Genetic Medicine, and Department of Pediatrics.
Dr. Hudson holds a PhD in Molecular Biology from the University of California at Berkeley, an MS in Microbiology from the University of Chicago, and a BA in Biology from Carleton College.
